Abstract | BACKGROUND:
Allergic rhinitis is a very frequent disease. H1 antihistamines have been used for treatment of allergic rhinitis for more than 5 decades. They differ in chemical structure, pharmacokinetics, pharmacodynamics, clinical efficacy and adverse effects. METHODS: We performed a detailed analysis of all available publications concerning the new H1-antihistamine bilasitine. RESULTS: CONCLUSION:
|
Authors | Krzysztof Kowal, Lawrence DuBuske |
Journal | American journal of rhinology & allergy
(Am J Rhinol Allergy)
2014 Jul-Aug
Vol. 28
Issue 4
Pg. 312-6
ISSN: 1945-8932 [Electronic] United States |
PMID | 25197918
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Benzimidazoles
- Histamine H1 Antagonists
- Piperidines
- bilastine
|
Topics |
- Animals
- Benzimidazoles
(pharmacokinetics, therapeutic use)
- Cross-Over Studies
- Dogs
- Double-Blind Method
- Histamine H1 Antagonists
(therapeutic use)
- Humans
- Piperidines
(pharmacokinetics, therapeutic use)
- Rats
- Rhinitis, Allergic
(drug therapy)
|